September 5, 2014

Purdue Pharma on Thursday presented results from two epidemiological studies evaluating the reformulation of OxyContin. 

September 5, 2014

Walgreens is offering more than $10 million worth of flu shot vouchers free to those without health insurance coverage.

 

September 4, 2014

BlueCross BlueShield of Western New York on Wednesday welcomed Walgreens to the health plan’s retail pharmacy network and named the retailer the plan's specialty pharmacy provider. 

September 4, 2014

The Drug Enforcement Administration National Prescription Drug Take-Back Day collection site locator is now available online, the National Association of Boards of Pharmacy reported Wednesday.

September 4, 2014

Healthcare Data Solutions on Wednesday announced that it ranked on Inc. 5000’s list of the fastest-growing private companies in the United States for the third year in a row, at No. 3,154 with 111% sales growth.

September 4, 2014

New research suggests that sleeping seven to eight hours per night is associated with the lowest risk of absence from work due to sickness, the National Healthy Sleep Awareness Project reported Wednesday.

September 4, 2014

Teva Pharmaceutical on Thursday announced the launch of generic Baraclude (entecavir) tablets in 0.5-mg and 1-mg dosage strengths. The company was the first to file, giving it 180 days of marketing exclusivity for the drug. 

September 4, 2014

Walgreens on Thursday reported August sales of $6.4 billion, an increase of 3.6% from the same month in fiscal 2013.

 

September 3, 2014

CVS Caremark announced today that it is changing its corporate name to CVS Health to reflect its broader healthcare commitment and its expertise in driving the innovations needed to shape the future of health.

September 3, 2014

To help prepare for the upcoming flu season, vaccinations are now available at all Giant Food in-store pharmacies.

September 3, 2014

The Department of Health and Human Services last week published a final rule that allows healthcare providers more flexibility in how they use certified electronic health record technology to meet meaningful use for an EHR Incentive Program reporting period for 2014. 

 

September 3, 2014

The National Institutes of Health has issued a final NIH Genomic Data Sharing policy to promote data sharing as a way to speed the translation of data into knowledge, products and procedures that improve health while protecting the privacy of research participants. 

September 3, 2014

PharmaSmart on Wednesday announced the debut of its next generation biometric kiosk, the Model PS2000 (D)estination, which recently completed a pilot inside Mariano’s, a grocer with 26 stores located in the Chicagoland Metro area. 

September 3, 2014

Teva Pharmaceutical on Wednesday announced the launch of SYNCareTM, a program designed to support patients taking Synribo (omacetaxine mepesuccinate) for at-home injection.

September 3, 2014

Teva Pharmaceutical on Wednesday announced that a positive judgment has been given by the U.K. High Court in support of Teva's case against AstraZeneca relating to the validity of EP 1,085,877 covering the SMART (Single inhaler Maintenance And Reliever Therapy) indication for AstraZeneca's fixed dose formoterol/budesonide combination product, Symbicort.

September 2, 2014

Acura Pharmaceuticals last week announced that it has been awarded a $300,000 grant by the National Institute On Drug Abuse of the National Institutes of Health to fund Phase I development of Acura's new, early stage Limitx abuse deterrent technology.

September 2, 2014

The asthma treatment market value will grow from approximately $15.9 billion in 2013 across eight major countries — the United States, United Kingdom, France, Germany, Spain, Italy, Japan and Australia — to $23.1 billion by 2023, according to research and consulting firm GlobalData.

September 2, 2014

UCB on Monday announced that the Food and Drug Administration has approved a supplemental new drug application for Vimpat (lacosamide) C-V as monotherapy in the treatment of partial-onset seizures in patients with epilepsy ages 17 years and older.

September 2, 2014

Sandoz last week announced the U.S. market introduction of decitabine for injection, a generic version of Eisai’s Dacogen.

September 2, 2014

ExceleraRx, a national specialty pharmacy network, last week named James Fox as its president and CEO, effective Sept. 1.

September 2, 2014

Among patients with hypertension at high risk of cardiovascular disease, a program where patients measured their blood pressure and adjusted their antihypertensive medication accordingly resulted in lower systolic blood pressure at 12 months compared with patients who received usual care, according to a study in the Aug. 27 issue of JAMA.

September 2, 2014

More than 55% of people suffer from swallowing difficulties when taking tablets or capsules, which is likely to inhibit compliance, according to an international survey conducted by Spiegel Institute Mannheim on behalf of Hermes Pharma. 

September 1, 2014

Pfizer and Protalix BioTherapeutics last week announced that the Food and Drug Administration approved Elelyso (taliglucerase alfa) for injection for pediatric patients.

September 1, 2014

Pfizer last week announced that the Food and Drug Administration has granted fast track designation to the company’s investigational Clostridium difficile (C. difficile) vaccine candidate (PF-06425090).